Cytotoxic effect caspase activation dependent of a genetically engineered fusion protein with a CD154 peptide mimetic (OmpC-CD154p) on B-NHL cell lines is mediated by the inhibition of bcl-6 and YY1 through MAPK p38 activation.

eScholarship, University of California 2019-04-02

The interaction between CD40, and its ligand, CD154, is essential for the development of humoral and cellular immune responses. The selective inhibition or activation of this pathway forms the basis for the development of new therapeutics against immunologically based diseases and malignancies. We are developing a gene fusion of Salmonella typhi OmpC protein expressing the CD154 Tyr140-Ser-149 amino acid strand. This OmpC-CD154 binds CD40 and activates B cells. In this study, we demonstrate that OmpC-CD154p treatment inhibits cell growth, proliferation and induced apoptosis in the B-NHL cell lines Raji and Ramos. The Bcl-2 family proteins were regulated and the Bcl-6 and YY1 oncoproteins were inhibited. p38 MAPK activation is an important mechanism underlying the effect on proliferation and apoptosis mediated by this fusion protein. This study establishes a basis for the possible use of fusion protein OmpC-CD154 as an alternative treatment for B-NHL.

Antineoplastic Agents: chemistry; pharmacology; Apoptosis: drug effects; CD40 Antigens: metabolism; CD40 Ligand: chemistry; Caspases: metabolism; Cell Cycle: drug effects; Cell Line; Tumor; Cell Survival: drug effects; Humans; Molecular Mimicry; Peptides: chemistry; Porins: chemistry; Proto-Oncogene Proteins c-bcl-6: metabolism; YY1 Transcription Factor: metabolism; p38 Mitogen-Activated Protein Kinases: metabolism; article

Open access content. Open access content
public

application/pdf
Leukemia & lymphoma vol 60, iss 4, 1062-101070 1029-2403

CDLER oai:escholarship.org:ark:/13030/qt3nj9g30m
qt3nj9g30m
https://escholarship.org/uc/item/3nj9g30m
https://escholarship.org/
1287365983

UC MASS DIGITIZATION
From OAIster®, provided by the OCLC Cooperative.

edsoai.on1287365983